A1 Refereed original research article in a scientific journal

Rates of Serious Infections and Malignancies Among Patients with Rheumatoid Arthritis Receiving Either Tumor Necrosis Factor Inhibitor or Rituximab Therapy

Authors: Kalle Jyri Aaltonen, Jaana Tuulikki Joensuu, Liisa Virkki, Tuulikki Sokka, Pasi Aronen, Heikki Relas, Heikki Valleala, Vappu Rantalaiho, Laura Pirilä, Kari Puolakka, Tea Uusitalo, Marja Blom, Yrjö Tapio Konttinen, Dan Nordström

Publisher: Journal of Rheumatology Publishing Co. Ltd.

Publication year: 2015

Journal: Journal of Rheumatology

Volume: 42

Issue: 3

First page : 372

Last page: 378

Number of pages: 7

ISSN: 0315-162X

eISSN: 1499-2752

DOI: https://doi.org/10.3899/jrheum.140853